Document Detail


Alteration of fatty acid and sterol metabolism in miltefosine-resistant Leishmania donovani promastigotes and consequences for drug-membrane interactions.
MedLine Citation:
PMID:  15980336     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Miltefosine (hexadecylphosphocholine [HePC]) is the first orally active drug approved for the treatment of visceral leishmaniasis. In order to investigate the biochemical modifications occurring in HePC-resistant (HePC-R) Leishmania donovani promastigotes, taking into account the lipid nature of HePC, we investigated their fatty acid and sterol metabolisms. We found that the content of unsaturated phospholipid alkyl chains was lower in HePC-R parasite plasma membranes than in those of the wild type, suggesting a lower fluidity of HePC-R parasite membranes. We also demonstrated that HePC insertion within an external monolayer was more difficult when the proportion of unsaturated phospholipids decreased, rendering the HePC interaction with the external monolayer of HePC-R parasites more difficult. Furthermore, HePC-R parasite membranes displayed a higher content of short alkyl chain fatty acids, suggesting a partial inactivation of the fatty acid elongation enzyme system in HePC-R parasites. Sterol biosynthesis was found to be modified in HePC-R parasites, since the 24-alkylated sterol content was halved in HePC-R parasites; however, this modification was not related to HePC sensitivity. In conclusion, HePC resistance affects three lipid biochemical pathways: fatty acid elongation, the desaturase system responsible for fatty acid alkyl chain unsaturation, and the C-24-alkylation of sterols.
Authors:
M Rakotomanga; M Saint-Pierre-Chazalet; P M Loiseau
Related Documents :
1362756 - Irradiation of langmuir-blodgett multilayer preparations of phospholipids and a fatty a...
4342556 - Metabolism of fatty acids by bovine spermatozoa.
17403096 - Fibrinolysis in a lipid environment: modulation through release of free fatty acids.
7628726 - Preferential formation of the hydroperoxide of linoleic acid in choline glycerophosphol...
9218706 - Induction of fatty acid synthesis by pravastatin sodium in rat liver and primary hepato...
8759156 - Improved synthesis and characterisation of a hydrazide derivative of diethylenetriamine...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Antimicrobial agents and chemotherapy     Volume:  49     ISSN:  0066-4804     ISO Abbreviation:  Antimicrob. Agents Chemother.     Publication Date:  2005 Jul 
Date Detail:
Created Date:  2005-06-27     Completed Date:  2005-08-19     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  0315061     Medline TA:  Antimicrob Agents Chemother     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2677-86     Citation Subset:  IM    
Affiliation:
Chimiothérapie Antiparasitaire, UMR 8076 CNRS, Faculté de Pharmacie, Université Paris XI, F-92290, Chātenay-Malabry, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antiprotozoal Agents / pharmacology*,  therapeutic use
Cell Membrane / drug effects,  metabolism
Drug Resistance*
Fatty Acids / metabolism*
Humans
Leishmania donovani / drug effects*,  growth & development
Leishmaniasis, Visceral / drug therapy,  parasitology
Parasitic Sensitivity Tests
Phosphorylcholine / analogs & derivatives*,  pharmacology*,  therapeutic use
Sterols / metabolism*
Chemical
Reg. No./Substance:
0/Antiprotozoal Agents; 0/Fatty Acids; 0/Sterols; 107-73-3/Phosphorylcholine; 58066-85-6/miltefosine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Correlation between ratio of serum doxycycline concentration to MIC and rapid decline of antibody le...
Next Document:  Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein corr...